D-0634-2022 Class I Terminated

Recalled by STAQ Pharma, Inc. — Denver, CO

FDA drug recall D-0634-2022 was initiated by STAQ Pharma, Inc. on Feb 3, 2022 and is designated Class I. Reason for recall: Labeling: Label Mix up; A limited number of syringes containing HYDROmorphone HCl PF were incorrectly labeled as Morphine Sulfate PF with lot number 21104221A The recall status is terminated (terminated Sep 16, 2022).

Recall details

Product Type
Drugs
Report Date
Feb 23, 2022
Initiation Date
Feb 3, 2022
Termination Date
Sep 16, 2022
Voluntary/Mandated
Voluntary: Firm initiated

Product description

Morphine Sulfate PF 25 mg/25mL (1 mg/mL) in NaCl, 25 mL in 30 mL Single Dose Syringe, Rx only, STAQ Pharma, Inc., Denver, CO 80239, NDC: 73177-0105-04.

Reason for recall

Labeling: Label Mix up; A limited number of syringes containing HYDROmorphone HCl PF were incorrectly labeled as Morphine Sulfate PF with lot number 21104221A

Distribution pattern

CO, OH, and TX.

Code information

Lot Number: 21104221A, Expiration date: 05-22-2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0634-2022
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0634-2022. Report a data issue: hello@regdatalab.com.